Groningen Institute for Kidney Diseases (GIKD)
Research programme
Mission and objectives
- To identify the pathophysiological mechanisms of progressive loss of renal function
- To identify the link between renal and cardiovascular complications of common risk factors
- To develop strategies for the prevention of renal and related cardiovascular function loss and to resolve individual therapy resistance, based on insight into these mechanisms
Research Area
The programme studies these pathways and the potential therapeutic interventions under three sets of circumstances, thereby
integrating experimental, clinical, and epidemiological approaches. Thus, three sub-programmes are operative.
1. Renal function in normal subjects. Little is known about the incidence and magnitude of renal function loss in
the general population (i.e. in subjects not previously diagnosed as having renal disease), and the mechanisms
underlying the susceptibility to renal damage in healthy subjects, including common pathways with cardiovascular disease. This sub-programme is divided into
three research lines:
a. Mechanisms of renal function loss and its complications
b. Kidney-Heart and Kidney-Vessel interactions
c. Detection strategies and therapeutic interventions
2. Renal diseases of various origin. It has been well documented that a patient who experienced a certain type of
renal disease will progress to end stage renal failure, independent of the type of the initial renal insult.
This sub-programme is divided into
three research lines:
a. Mechanisms of renal function loss and its complications
b. Kidney-Heart and Kidney-Vessel interactions
c. Therapeutic interventions
3. Renal transplantation. Because the mechanisms underlying chronic renal transplant dysfunction overlap the
mechanisms underlying renal function loss in diseases of native kidneys, the mechanisms as studied in diseases
of native kidneys are also evaluated in renal transplantation. This sub-programme is divided into
three research lines:
a. Mechanisms of renal function loss and its complications
b. Kidney-Heart and Kidney-Vessel interactions
c. Therapeutic interventions
Contact
Programme leaders
Name: Prof.Dr. Paul E. de Jong
Phone: +31 (0) 50 361 3434
e-mail Prof. de Jong
address:
Department of Internal Medicine Nephrology
Groningen University Medical Center
Hanzeplein 1
P.O. Box 30.001
NL-9700 RB Groningen
Name: Prof.Dr. Dick de Zeeuw
Phone: + 31 (0)50 363 2838
e-mail Prof. de Zeeuw
address:
Deptartment of Clinical Pharmacology
Groningen University Medical Center
Antonius Deusinglaan 1
PO.box 196
NL- 9700 AD Groningen
